Oncology Is Not for the Faint of Heart
By Pesona Grace Lucksom, MBBS, MSI rushed out of the patient’s room and sat on a chair. I hurriedly covered my face with the palm of my hands as I did not want anyone to see me cry. I desperately ordered my tears not to roll down my cheeks but they didn't listen to...
Changing The Narrative: 10 Recommendations for Caring for Young Adults With Lung Cancer
By Narjust Florez, MD, Fatima Wilder, MD, MSc, Lauren Kiel, BS, and Rebekah Kaufman, MSIt is about time that we change the narrative of lung cancer being a disease that impacts elderly men with a smoking history into one that encompasses our modern reality of an inclusive patient population, including women and especially including...
Celebrating the 18th Annual Best of ASCO in Beirut
It was such a great pleasure and satisfaction to organize and hold the 18th Annual Best of ASCO (BOA) Lebanon Meeting on July 7-8, 2023, at the American University of Beirut Medical Center (AUBMC) in a hybrid format from the Daniel ACC Building Ground Floor Conference Rooms. Speakers and attendees in Lebanon were present...
I Travel for Global Oncology: The Tale of My Great Journey at the University of Lahore in Pakistan
By Khalid El Bairi, MDOn a beautiful morning in early October 2022, I received a WhatsApp message from an enthusiastic young professor of pharmacy, Dr. Faisal Gulzar, who invited me to deliver presentations in a country very far from my home in Morocco—Pakistan! A country that I've never visited and that I mostly know...
Ovarian Cancer Risk Lower With Daily Aspirin, Despite Genetics
The new findings indicate frequent aspirin use provides a protective effect against nonmucinous ovarian cancer, regardless of a person's genetic susceptibility. Medscape Medical News
Renewed Calls for Fallopian Tube Removal to Avoid Ovarian Cancer
Renewed calls for all women to consider having their fallopian tubes removed once they have finished with childbearing come from the Ovarian Cancer Research Alliance. Medscape Medical News
FDA Expands Approval of Imaging Agent Cytalux for Lung Cancer
The expanded indication for pafolacianine (Cytalux) follows an initial approval in November 2021 for use in patients with ovarian cancer. Medscape Medical News
Test Predicts Which BC Patients Benefit From Ovarian Suppression
Using the Breast Cancer Index earlier could identify premenopausal HR+ breast cancer patients who benefit from ovarian function suppression, suggests analysis. Medscape Medical News
New Findings on Rare Mucinous Ovarian Cancer May Change Tx
A global study of the microscopic patterns of cell growth in samples taken from women with this rare form of ovarian cancer may lead to treatment changes for some. Medscape Medical News
Preventing Doxorubicin-Induced Hand-Foot Syndrome
Dexamethasone plus wrist and ankle cooling may prevent hand-foot syndrome from doxorubicin in patients with ovarian cancer. The study was published as a preprint and has not yet been peer reviewed. First Look
